{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:11:24Z","timestamp":1793236284541,"version":"4.5.0"},"reference-count":52,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2010,5,27]],"date-time":"2010-05-27T00:00:00Z","timestamp":1274918400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Immunogenetics"],"published-print":{"date-parts":[[2010,10]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The aim of this study was to determine the rate of <jats:italic>MEFV<\/jats:italic> gene mutations, the gene responsible for familial Mediterranean fever (FMF), in patients with hematolymphoid neoplasm. The rate of the five most common <jats:italic>MEFV<\/jats:italic> gene mutations (M694V, M680I, V726A, M694I and E148Q) was determined in 46 patients with hematolymphoid neoplasm. We found a high frequency of carriers in patients with multiple myeloma (60%) and acute lymphocytic leukaemia (33.3%), whereas patients with chronic lymphocytic leukaemia (9%) and non\u2010Hodgkin lymphoma (5%) had a low mutation carrier rate. There is no <jats:italic>MEFV<\/jats:italic> gene mutation in patients with Hodgkin lymphoma. Furthermore, the statistically significant predominance of strong heterozygous mutations such as M694V and M680I in patients with hematolymphoid neoplasm; none had own and\/or family history compatible with FMF, is interesting. In conclusion, we found a high frequency of carriers for <jats:italic>MEFV<\/jats:italic> gene in patients with multiple myeloma and acute lymphocytic leukaemia. The data of our study may provide some new insights in understanding of individual genetic differences in susceptibility to these neoplasms.<\/jats:p>","DOI":"10.1111\/j.1744-313x.2010.00938.x","type":"journal-article","created":{"date-parts":[[2010,5,27]],"date-time":"2010-05-27T12:10:48Z","timestamp":1274962248000},"page":"387-391","source":"Crossref","is-referenced-by-count":14,"title":["The rate of <i>MEFV<\/i> gene mutations in hematolymphoid neoplasms"],"prefix":"10.1111","volume":"37","author":[{"given":"S.","family":"Celik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. A.","family":"Erikci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Tunca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Sayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. M.","family":"Terekeci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. E.","family":"Umur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Torun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Tangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Top","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Oktenli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,9]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2007.07.004"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2008.00615.x"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-006-9004-4"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4400774"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4401888"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/7.10.1581"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1373520"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-01-134932"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/08830180802130327"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.22005"},{"key":"e_1_2_6_12_1","first-page":"6236","article-title":"TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation\u2010induced gene silencing in human breast cancers","volume":"60","author":"Conway K.E.","year":"2000","journal-title":"Cancer Research"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-007-0780-1"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.20600"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1110\/ps.13801"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4402194"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/93.4.223"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.21.11848"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.1.3"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81683-9"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri1703"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2007.07.003"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2006.06.011"},{"key":"e_1_2_6_24_1","first-page":"2070","article-title":"The rate of pyrin mutations in critically ill patients with systemic inflammatory response syndrome and sepsis: a pilot study","volume":"34","author":"Koc B.","year":"2007","journal-title":"Journal of Rheumatology"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401705"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0b013e328302c7f4"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2003.07.007"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112208200"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-9822(01)00056-2"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.48.33835"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1155\/2009\/287387"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1023\/B:APPT.0000012117.32430.0c"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2005.05.010"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2004.02632.x"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4402142"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M104730200"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/85893"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri1629"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C200179200"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20021552"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1517\/14728222.9.5.1045"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1097\/bor.0000174210.78449.6b"},{"key":"e_1_2_6_43_1","first-page":"2024","article-title":"Increased asymmetric dimethylarginine levels in young men with familial Mediterranean fever (FMF): is it early evidence of interaction between inflammation and endothelial dysfunction in FMF?","volume":"35","author":"Terekeci H.M.","year":"2008","journal-title":"Journal of Rheumatology"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-008-0648-y"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng0997-25"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80539-5"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/356768a0"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.4.1451.004k52_1451_1455"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejhg.5200658"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)00067-4"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M203915200"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0968-0004(01)01905-3"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejhg.5200674"}],"container-title":["International Journal of Immunogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1744-313X.2010.00938.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1744-313X.2010.00938.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T08:28:19Z","timestamp":1698654499000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1744-313X.2010.00938.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["10.1111\/j.1744-313X.2010.00938.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1744-313x.2010.00938.x","archive":["Portico"],"relation":{},"ISSN":["1744-3121","1744-313X"],"issn-type":[{"value":"1744-3121","type":"print"},{"value":"1744-313X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}